112 related articles for article (PubMed ID: 9544432)
1. Immunohistochemical prediction of radiation response and local control in radiation therapy for cervical cancer.
Nakano T; Oka K; Ishikawa A; Morita S
Cancer Detect Prev; 1998; 22(2):120-8. PubMed ID: 9544432
[TBL] [Abstract][Full Text] [Related]
2. Correlation of cervical carcinoma c-erb B-2 oncogene with cell proliferation parameters in patients treated with radiation therapy for cervical carcinoma.
Nakano T; Oka K; Ishikawa A; Morita S
Cancer; 1997 Feb; 79(3):513-20. PubMed ID: 9028362
[TBL] [Abstract][Full Text] [Related]
3. Differential values of Ki-67 index and mitotic index of proliferating cell population. An assessment of cell cycle and prognosis in radiation therapy for cervical cancer.
Nakano T; Oka K
Cancer; 1993 Oct; 72(8):2401-8. PubMed ID: 8402456
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of mitotic index of proliferating cell populations in cervical cancer patients treated with carbon ion beam.
Suzuki Y; Oka K; Ohno T; Kato S; Tsujii H; Nakano T
Cancer; 2009 May; 115(9):1875-82. PubMed ID: 19224551
[TBL] [Abstract][Full Text] [Related]
5. Markers of radioresistance in squamous cell carcinomas of the head and neck: a clinicopathologic and immunohistochemical study.
Raybaud-Diogène H; Fortin A; Morency R; Roy J; Monteil RA; Têtu B
J Clin Oncol; 1997 Mar; 15(3):1030-8. PubMed ID: 9060543
[TBL] [Abstract][Full Text] [Related]
6. Manganese superoxide dismutase expression correlates with p53 status and local recurrence of cervical carcinoma treated with radiation therapy.
Nakano T; Oka K; Taniguchi N
Cancer Res; 1996 Jun; 56(12):2771-5. PubMed ID: 8665512
[TBL] [Abstract][Full Text] [Related]
7. [Correlation of CerbB-2 to Ki-67 and P53 expressions in hormone-independent breast cancer].
Fang Q; Wang XF
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Feb; 31(2):380-2. PubMed ID: 21354936
[TBL] [Abstract][Full Text] [Related]
8. Squamous cell carcinoma of the oropharynx: Ki-67 and p53 can identify patients at high risk for local recurrence after surgery and postoperative radiotherapy.
Grabenbauer GG; Mühlfriedel C; Rödel F; Niedobitek G; Hornung J; Rödel C; Martus P; Iro H; Kirchner T; Steininger H; Sauer R; Weidenbecher M; Distel L
Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1041-50. PubMed ID: 11072161
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of immunohistochemically detected p53 protein expression in stage IIIB squamous cell carcinoma of the uterine cervix treated with radiation therapy alone.
Ebara T; Mitsuhashi N; Saito Y; Sakurai H; Hasegawa M; Takahashi M; Takahashi T; Hayakawa K; Niibe H
Gynecol Oncol; 1996 Nov; 63(2):216-8. PubMed ID: 8910630
[TBL] [Abstract][Full Text] [Related]
10. Correlation among six biologic factors (p53, p21(WAF1), MIB-1, EGFR, HER2, and Bcl-2) and clinical outcomes after curative chemoradiation therapy in squamous cell cervical cancer.
Yamashita H; Murakami N; Asari T; Okuma K; Ohtomo K; Nakagawa K
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1165-72. PubMed ID: 19101092
[TBL] [Abstract][Full Text] [Related]
11. Altered expression of mdm-2 and its association with p53 protein status, tumor-cell-proliferation rate and prognosis in cervical neoplasia.
Dellas A; Schultheiss E; Almendral AC; Gudat F; Oberholzer M; Feichter G; Moch H; Torhorst J
Int J Cancer; 1997 Aug; 74(4):421-5. PubMed ID: 9291432
[TBL] [Abstract][Full Text] [Related]
12. The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.
Korkolopoulou P; Christodoulou P; Kapralos P; Exarchakos M; Bisbiroula A; Hadjiyannakis M; Georgountzos C; Thomas-Tsagli E
Pathol Res Pract; 1997; 193(11-12):767-75. PubMed ID: 9521509
[TBL] [Abstract][Full Text] [Related]
13. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
[TBL] [Abstract][Full Text] [Related]
14. Studies on tumor proliferation using monoclonal antibody, Ki 67 and expression of p53 in cancer of the uterine cervix.
Bar JK; Harlozinska A; Markowska J; Nowak M
Eur J Gynaecol Oncol; 1996; 17(5):378-80. PubMed ID: 8933835
[TBL] [Abstract][Full Text] [Related]
15. [Overexpression of c-erbB-2 and p53 oncoprotein in renal pelvic and ureteral carcinomas with reference to the expression of Ki-67 antigen as a proliferation marker].
Hashimoto H; Sue Y; Tokumitsu M; Saga Y; Yachiku S
Nihon Hinyokika Gakkai Zasshi; 1997 Jun; 88(6):605-11. PubMed ID: 9234617
[TBL] [Abstract][Full Text] [Related]
16. The combination of p53 and age predict cancer specific death in advanced stage (FIGO Ic-IV) of endometrial carcinoma of endometrioid type. An immunohistochemical examination of growth fraction: Ki-67, MIB-1 and PC10; suppressor oncogene protein: p53; oncogene protein: p185 and age, hormone treatment, stage, and histologic grade.
Nielsen AL; Nyholm HC
Eur J Obstet Gynecol Reprod Biol; 1996 Dec; 70(1):79-85. PubMed ID: 9031925
[TBL] [Abstract][Full Text] [Related]
17. Expression of hypoxic-inducible factor 1alpha predicts metastasis-free survival after radiation therapy alone in stage IIIB cervical squamous cell carcinoma.
Ishikawa H; Sakurai H; Hasegawa M; Mitsuhashi N; Takahashi M; Masuda N; Nakajima M; Kitamoto Y; Saitoh J; Nakano T
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):513-21. PubMed ID: 15380586
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of p53, c-erbB-2 and epidermal growth factor receptor on head and neck carcinoma.
Parise Junior O; Carvalho LV; Miguel RE; Kowalski LP
Sao Paulo Med J; 2004 Nov; 122(6):264-8. PubMed ID: 15692721
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of bcl-2, p53 and Ki-67 in invasive squamous carcinoma of the uterine cervix.
Padovan P; Salmaso R; Marchetti M; Padovan R
Eur J Gynaecol Oncol; 2000; 21(3):267-72. PubMed ID: 10949392
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of tumor markers in colorectal cancer patients: DNA index, S-phase fraction, p53 expression, and Ki-67 index.
Chen YT; Henk MJ; Carney KJ; Wong WD; Rothenberger DA; Zheng T; Feygin M; Madoff RD
J Gastrointest Surg; 1997; 1(3):266-72; discussion 273. PubMed ID: 9834357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
